AffyImmune Therapeutics Awarded Best Oncology R&D Advance Scrip Award 2023
/PRNewswire/ -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid tumors, was...
Source: prnewswire.com